Across TCGA pan-cancer cohorts, BMPR1AP1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated BMPR1AP1 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher BMPR1AP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BMPR1AP1 expression acts as an unfavorable survival marker, although some lineages such as UCS and LGG show a favorable association.
BLCA, UVM, and UCS are the cancer types where BMPR1AP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.